Drugs before transplant may boost liver cancer survival
NCT ID NCT07418138
Summary
This study looked back at nearly 500 liver cancer patients who received a liver transplant. Researchers wanted to see if taking certain cancer-fighting drugs (tyrosine kinase inhibitors) before the transplant surgery helped control the cancer better. They checked if the drugs led to fewer cancer returns and longer survival after the transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Affiliated Hospital Xian Jiaotong University
Xi'an, Shaanxi, 710061, China
Conditions
Explore the condition pages connected to this study.